Cholangiocarcinoma is a rare cancer that develops in the bile ducts, which carry digestive fluid from the liver to the small intestine. It is caused by malignant transformation of cells lining the bile ducts, often linked to chronic inflammation, bile duct stones, or liver fluke infections. The Carbohydrate Antigen (CA) 19-9 test is the most important blood test for monitoring treatment response and disease progression in cholangiocarcinoma patients.
90-day money-back guarantee
Lab order in minutes
Save a trip to the doctor
Low prices since 2005
Labs within 2 miles
Cholangiocarcinoma is caused by malignant transformation of epithelial cells that line the bile ducts. Several risk factors contribute to this cancer, including chronic inflammation from primary sclerosing cholangitis, bile duct stones (choledocholithiasis), parasitic liver fluke infections (Opisthorchis viverrini and Clonorchis sinensis), congenital bile duct abnormalities like choledochal cysts, and chronic hepatitis B or C infections. Exposure to certain toxins like Thorotrast (a contrast agent) and industrial chemicals also increases risk. Most cases occur in people over 50, though the exact trigger for cell mutation often remains unknown.
The Carbohydrate Antigen (CA) 19-9 test is the most important blood test for cholangiocarcinoma because it detects elevated levels of this tumor marker that often rise when bile duct cancer is present. While CA 19-9 cannot definitively diagnose cholangiocarcinoma on its own, it is essential for monitoring how well treatment is working and tracking whether the cancer is progressing or responding to therapy. Diagnosis typically requires imaging studies like MRI or MRCP (magnetic resonance cholangiopancreatography) and tissue biopsy. However, CA 19-9 blood work provides a convenient way to track tumor activity over time, with levels typically decreasing when treatment is effective and rising if the cancer returns or spreads.
You should get tested if you experience persistent yellowing of your skin and eyes (jaundice), unexplained weight loss, intense itching all over your body, pale or clay-colored stools, dark urine, or abdominal pain in the upper right side. If you have risk factors like primary sclerosing cholangitis, chronic liver disease, bile duct stones, or a history of liver fluke infection and develop any of these symptoms, testing becomes even more critical. People with diagnosed cholangiocarcinoma should have regular CA 19-9 testing to monitor treatment effectiveness and catch any recurrence early.
Save a trip to the doctor, go directly to the lab
Instant orders, results often overnight*
Results explained in simple language
Reviewed by US licensed doctors
Fast & confidential, we never sell or share your data
No insurance needed, transparent pricing
What this means
Your CA 19-9 level is slightly above the normal reference range. While this is a mild elevation and not necessarily concerning on its own, it warrants monitoring and discussion with your healthcare provider, especially if you have gastrointestinal symptoms or a history of digestive conditions.
Recommended actions
Discuss results with your doctor to determine if additional imaging or testing is needed
Keep a symptom diary noting any abdominal pain, digestive changes, or unexplained weight loss
Maintain a healthy diet rich in vegetables, fruits, and whole grains while limiting processed foods
Retest in 2-3 months to establish a baseline trend and monitor for changes
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
3303 reviews
Sample results
Your 24/7 Personal Lab Guide
Quick questions:
